Fulgent Genetics (FLGT) Change in Acquisitions & Divestments (2017 - 2026)

Fulgent Genetics has disclosed Change in Acquisitions & Divestments across 10 years of filings, most recently posting $81.7 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $81.7 million, up 151.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $260.3 million (down 9.25% YoY), and the FY2025 annual result was $211.0 million, down 39.68% from the prior year.
• Change in Acquisitions & Divestments came in at $81.7 million for Q1 2026 at Fulgent Genetics, up from $78.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $141.4 million in Q1 2023 to a low of $27.8 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $78.1 million (2025), against an average of $81.4 million.
• Across the five-year window, Change in Acquisitions & Divestments surged 409.39% in 2023 and plunged 66.01% in 2025, its largest moves.
• Fulgent Genetics' Change in Acquisitions & Divestments stood at $100.8 million in 2022, then jumped by 30.6% to $131.7 million in 2023, then plunged by 45.48% to $71.8 million in 2024, then gained by 8.79% to $78.1 million in 2025, then advanced by 4.63% to $81.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $81.7 million (Q1 2026), $78.1 million (Q4 2025), and $40.2 million (Q3 2025), per Business Quant data.